Form 4 for MDCX Medicus Pharma Ltd.
Accepted 2025-05-21 00:00:00 ET · period of report 2025-05-20 · accession 0001671948-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-05-21 | 2025-05-20 | MDCX | Melani Kenneth R. | 10% | S - Sale | $7.72 | -75.0K | 3.25M | -2% | -$579.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Medicus Pharma LTD | 2025-05-20 | S | D | 75,000 | $7.72 | 3,248,741 | I See Footnote | — | — | (F2) Represents 2,839,330 common shares held by Velocity Fund Partners, LP an entity controlled by Dr. Kenneth R. Melani and 409,411 common shares held directly by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership of common shares held by Velocity Fund Partners, LP, except to the extent of his pecuniary interest therein. |